2023-507753-15-00CompletedPhase 1
Study with healthy volunteers to investigate the safety, tolerability, blood concentration and some effects of various amounts of the pharmaceutical substance SR-878
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- SciRhom GmbH
- Enrollment
- 52
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Scientific contact point
Scientific
SciRhom GmbH
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with or without fluconazole2023-510472-31-00Janssen Cilag International18
Recruiting
Phase 1
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by food2024-519615-34-00Boehringer Ingelheim International GmbH17
Recruiting
Phase 1
A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body2025-521419-37-00Boehringer Ingelheim International GmbH16
Completed
Phase 1
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal2023-503528-25-00F. Hoffmann-La Roche AG, F. Hoffmann-La Roche AG36
Completed
Phase 1
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-068214972023-508371-36-00Pfizer Inc.6